FR2470133A1 - Nouveaux sels d'addition d'acides d'alcaloides de l'ergot et d'alcaloides du dihydro-ergot physiologiquement acceptables et amorphes aux rayons x, utiles comme medicaments et procede de leur preparation - Google Patents

Nouveaux sels d'addition d'acides d'alcaloides de l'ergot et d'alcaloides du dihydro-ergot physiologiquement acceptables et amorphes aux rayons x, utiles comme medicaments et procede de leur preparation Download PDF

Info

Publication number
FR2470133A1
FR2470133A1 FR8024632A FR8024632A FR2470133A1 FR 2470133 A1 FR2470133 A1 FR 2470133A1 FR 8024632 A FR8024632 A FR 8024632A FR 8024632 A FR8024632 A FR 8024632A FR 2470133 A1 FR2470133 A1 FR 2470133A1
Authority
FR
France
Prior art keywords
dihydro
ergot
acid addition
ray
alkaloids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8024632A
Other languages
English (en)
French (fr)
Other versions
FR2470133B3 (pt
Inventor
Milojka Mohar
Rudolf Rucman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lek Pharmaceuticals dd
Original Assignee
Lek Pharmaceuticals and Chemical Co dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals and Chemical Co dd filed Critical Lek Pharmaceuticals and Chemical Co dd
Publication of FR2470133A1 publication Critical patent/FR2470133A1/fr
Application granted granted Critical
Publication of FR2470133B3 publication Critical patent/FR2470133B3/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FR8024632A 1979-11-22 1980-11-20 Nouveaux sels d'addition d'acides d'alcaloides de l'ergot et d'alcaloides du dihydro-ergot physiologiquement acceptables et amorphes aux rayons x, utiles comme medicaments et procede de leur preparation Granted FR2470133A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU2867/79A YU41681B (en) 1979-11-22 1979-11-22 Process for preparing x-ray amorhous physiologically tolerated acid additional salts of ergot alcaloids and dihydroergot alcaloids

Publications (2)

Publication Number Publication Date
FR2470133A1 true FR2470133A1 (fr) 1981-05-29
FR2470133B3 FR2470133B3 (pt) 1982-09-03

Family

ID=25558910

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8024632A Granted FR2470133A1 (fr) 1979-11-22 1980-11-20 Nouveaux sels d'addition d'acides d'alcaloides de l'ergot et d'alcaloides du dihydro-ergot physiologiquement acceptables et amorphes aux rayons x, utiles comme medicaments et procede de leur preparation

Country Status (10)

Country Link
JP (1) JPS56164195A (pt)
BE (1) BE886262A (pt)
DE (1) DE3043832A1 (pt)
ES (1) ES496969A0 (pt)
FR (1) FR2470133A1 (pt)
GB (1) GB2063864B (pt)
LU (1) LU82945A1 (pt)
NL (1) NL8006341A (pt)
PT (1) PT72078B (pt)
YU (1) YU41681B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU87190A1 (fr) * 1988-04-06 1989-11-14 Wurth Paul Sa Machine de percage de trous de coulee d'un four a cuve

Also Published As

Publication number Publication date
YU286779A (en) 1983-06-30
ES8205796A1 (es) 1982-08-01
PT72078A (en) 1980-12-01
GB2063864A (en) 1981-06-10
GB2063864B (en) 1983-07-20
ES496969A0 (es) 1982-08-01
BE886262A (fr) 1981-03-16
FR2470133B3 (pt) 1982-09-03
DE3043832A1 (de) 1981-09-17
LU82945A1 (de) 1981-03-26
JPS56164195A (en) 1981-12-17
NL8006341A (nl) 1981-06-16
PT72078B (en) 1981-09-29
YU41681B (en) 1987-12-31

Similar Documents

Publication Publication Date Title
CA1274543A (fr) (-)-benzhydryl-sulfinylacetamide, procede de preparation et utilisation en therapeutique
US5354885A (en) Process for preparing ethyl ester of L-DOPA
US5607969A (en) L-DOPA ethyl ester to treat Parkinson's disease
RU2128160C1 (ru) Трометаминная соль (+)-(s)-2-(3-бензоилфенил)пропионовой кислоты, способ ее получения, фармацевтическая композиция
FR2553409A1 (fr) Nouveaux benzenesulfonyl-lactames, leur procede de preparation et leur application comme substance active de compositions pharmaceutiques
FR2533919A1 (fr) Derives a activite biologique de la 2,5-piperazinedione, procedes pour leur preparation et compositions pharmaceutiques les contenant
EP0001021B1 (fr) Nouveaux dérivés d'alcaloides pentacycliques, procédé de préparation, application à la synthèse de produits du groupe de l'éburnamonine et compositions pharmaceutiques
FR2662940A1 (fr) Utilisation de derives de la tetrahydro isoquinoleine pour la preparation de medicaments anti-tumoraux, application a titre de medicaments de derives de la tetrahydro isoquinoleine et produits derives de cette structure.
FR2470133A1 (fr) Nouveaux sels d'addition d'acides d'alcaloides de l'ergot et d'alcaloides du dihydro-ergot physiologiquement acceptables et amorphes aux rayons x, utiles comme medicaments et procede de leur preparation
FI85142C (fi) Foerfarande foer framstaellning av ergolinestrar.
KR20170071431A (ko) 오로트산 l-카르니틴의 결정질 다형체, 이의 제조방법 또는 용도
US4183939A (en) Glaucine analgesic method
EP0384088B1 (fr) La (+) 1-[(3,4,5-triméthoxy) benzyloxyméthyl]-1-phényl-N,N-diméthyl-n-propylamine, son procédé de préparation et son application en thérapeutique
CA2442472A1 (en) Therapeutic agent for bladder irritative symptoms associated with benign prostatic hyperplasia
LU83962A1 (fr) Nouveau compose utile comme medicament antitussif et son procede de preparation
EP0034521B1 (fr) Médicament analgésique contenant de la 1-(3'benzofuryl)-4-benzylpipérazine et son procédé de préparation
FR2458552A1 (fr) Nouveaux alcaloides peptidiques de l'ergot de seigle, leur preparation et leur application comme medicaments
PL156473B1 (pl) Sposób wytwarzania nowych /aryloalkilo/aminP ie r w s z e n s t w o :21.12.1987,SE,8705089-4 25.11.1988,SE,8804277-5 PL PL PL
CH628321A5 (en) Process for the preparation of derivatives of isobutyramide and medical composition containing these derivatives
LU87439A1 (fr) Nouveaux derives de l'ergoline,leur preparation et leur utilisation comme medicaments
FR2597341A1 (fr) Solution pharmaceutique contenant de chelates de l-3,4-dihydroxyphenyl-alpha-methylalanine et procede pour la preparation de celle-ci.
FR2539739A1 (fr) Nouveaux derives de la naphtyl pyridazine actifs sur le systeme nerveux central, procede de preparation de ces derives et medicaments en contenant
FR2521562A1 (fr) Nouveaux alcaloides ergopeptidiques, leur preparation et medicaments contenant ces composes
FR2555899A1 (fr) Composition pharmaceutique contenant au moins un derive d'acide glycyrrhetinique et au moins un derive de xanthine
FR2583756A1 (fr) Procede de preparation des derives de la 2-halo-nicergoline et leurs sels d'addition avec des acides ainsi que des 2-halonicergolines nouvelles, compositions comportant des 2-halonicergolines et procede de preparation